Growing diagnostic test developer Nodality Inc. is losing its first CEO, but…
Super UserApril 26, 2012
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in…
Super UserApril 25, 2012
BALTIMORE, MARYLAND, April 24, 2012 – The University of Maryland BioPark announced…
Super UserApril 25, 2012
Rockville-based Human Genome Sciences Inc., which last week rejected an unsolicited $2.6…
Super UserApril 25, 2012
Venture capital dollars flowing to Maryland companies were down almost 30 percent…
Super UserApril 25, 2012